Conferences  >  Medicine & Healthcare  >  Translational Medicine, Clinical Trials  >  United States

FDAMap

By participating in this training, you will gain a deep understanding of the FDA's GMP expectations for Phase I and First-in-Man Clinical Trials. You will learn practical strategies that will enable you to navigate the regulatory landscape more effectively, ensuring FDA compliance while optimizing your resources.

Gmp, Clinical Trials, FDA Regulations, FDA Compliance,

Regulation in Medicine and Pharmacology,    Pharmacology and Drug Development

International Society for Cell & Gene Therapy

Clinical pathology,    Stem-cell Research & Therapy

FDAMap

Many pharmaceutical, biotechnology, and medical device companies engage one or more Clinical Research Organizations (CROs) to conduct their clinical trials. However, managing a study through a CRO presents unique challenges compared to in-house operations, yet companies frequently lack formal training for this transition. Moreover, the recent update to the ICH Good Clinical Practice (GCP) guidelines underscores the Sponsor's responsibility to actively oversee their trials. Regulatory agencies are increasingly scrutinizing this aspect, identifying it as a potential weakness within Sponsor companies. This workshop addresses these critical issues by providing comprehensive training on effective CRO oversight. Participants will gain the knowledge and skills necessary to navigate the complexities of managing CRO-run projects, ensuring regulatory compliance, and optimizing trial outcomes. Through interactive sessions and practical insights, attendees will learn how to enhance their oversight practices and strengthen their organization's approach to clinical trial management.

Cro, Clinical Trial, Clinical Research Organizations, FDA Regulations, FDA Compliance